Showing results (191-200 of 392) with videos related to
Sort By:
Pageof 40
The Journal of Biological Chemistry|April 7, 2000
Biosynthesis of PF1022A and related cyclooctadepsipeptidesW Weckwerth, K Miyamoto, K Iinuma, et al.The Annals of Pharmacotherapy|October 1, 1994
Safety and tolerance of intravenous nimodipineJ J Sramek, A H Heller, P R Sundaresan, et al.Journal of Clinical Pharmacology|June 1, 1990
Clinical safety, tolerance, and plasma levels of the oral anticholinesterase 1,2,3,4-tetrahydro-9-aminoacridin-1-oL-maleate (HP 029) in Alzheimer's disease: preliminary findingsN R Cutler, M F Murphy, R J Nash, et al.British Journal of Clinical Pharmacology|November 1, 1994
Pharmacokinetics of co-administered didanosine and stavudine in HIV-seropositive male patientsR D Seifert, M B Stewart, J J Sramek, et al.Life Sciences|January 1, 1996
Safety/tolerability trial of SDZ ENA 713 in patients with probable Alzheimer's diseaseJ J Sramek, R Anand, T S Wardle, et al.Life Sciences|January 1, 1995
Safety and tolerability of CI-979 in patients with Alzheimer's diseaseJ J Sramek, A J Sedman, P A Reece, et al.Journal of Human Hypertension|November 1, 1995
Anti-hypertensive effects of intravenous compared with oral captoprilJ J Sramek, J J Brennan, D R Much, et al.Clinical Pharmacokinetics|April 4, 2002
Estimation of the absolute bioavailability of rivastigmine in patients with mild to moderate dementia of the Alzheimer's typeMohammad Hossain, Stanford S Jhee, Thomas Shiovitz, et al.Archives of Neurology|June 1, 1988
One-year follow-up of infants with abstinence-associated seizuresT M Doberczak, S Shanzer, R Cutler, et al.Biological Psychiatry|April 1, 1984
Effects of chronic desipramine on plasma norepinephrine concentrations and cardiovascular parameters in elderly depressed women: a preliminary reportN R Cutler, A P Zavadil, M Linnoila, et al.Pageof 40